Phase 1 ALS Trial is First to Test Antisense Treatment of Neurodegenerative Disease

News   Apr 09, 2013

 
Phase 1 ALS Trial is First to Test Antisense Treatment of Neurodegenerative Disease
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE